- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 491/14 - Ortho-condensed systems
Patent holdings for IPC class C07D 491/14
Total number of patents in this class: 212
10-year publication summary
|
16
|
27
|
19
|
12
|
9
|
13
|
3
|
19
|
10
|
7
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5909 |
13 |
| Millennium Pharmaceuticals, Inc. | 488 |
7 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
5 |
| Rutgers, The State University of New Jersey | 1776 |
5 |
| Genentech, Inc. | 3742 |
4 |
| Amgen Inc. | 3779 |
4 |
| Nycomed GmbH | 87 |
4 |
| Jubilant Biosys Limited | 19 |
4 |
| Rigel Pharmaceuticals, Inc. | 613 |
4 |
| Fundacion Del Sector Publico Estatal Centro Nacional de Investigaciones Oncologicas Carlos III (f.s.p. Cnio) | 51 |
4 |
| Convalife (Shanghai) Co., Ltd. | 16 |
4 |
| Sudo Biosciences Limited | 16 |
4 |
| Novartis AG | 11238 |
3 |
| Bristol-myers Squibb Company | 5080 |
3 |
| F. Hoffmann-La Roche AG | 7958 |
3 |
| LG Chem, Ltd. | 17205 |
3 |
| Epizyme, Inc. | 383 |
3 |
| Gilead Sciences, Inc. | 1879 |
3 |
| ScinoPharm Taiwan, Ltd. | 131 |
3 |
| ImmuneTarget, Inc. | 7 |
3 |
| Other owners | 126 |